Animal Vaccines Market Share, and Competitive Landscape – Analysis and Forecast (2018-2025)

02th November 2018: The animal vaccines helps in the improvement of animal health in a cost effective manner by increasing the livestock production and preventing disease transmissions among animals. Animal vaccines market has gained a two-digit growth over the past few years. The ****** market for vet vaccines is driven by several factors like animal’s vulnerability to fatal diseases, and rapid change of diseases pattern among the animals. Veterinary vaccines have helped to reduce the heavy usage of drug treatments to curtail fatal diseases thereby preventing long term suffering and death.  The ****** animal vaccines market has changed progressively during the past years with the increase usage of continuing cell lines as substrates and for antigen production adopting fermenting technology. Depending on the vaccine characteristics these vaccines are consumed either by parenteral or by oral routes. The ****** animal vaccines market has four segments like diseases, products, regions and technologies. The disease segment animal vaccines market is further divided into aquaculture diseases, poultry diseases, companion animal diseases, equine diseases and porcine diseases.

Browse Full Research Report @

Porcine diseases include Porcine parvovirus, Porcine reproductive respiratory syndrome (PRRS), Porcine circovirus II, Swine influenza, Swine pneumonia, Auzeszky’s disease. Poultry diseases include Infectious bronchitis, Gumboro disease, Avian influenza, Coccidiosis, Marek’s disease, Newcastle disease, Mycoplasma. Equine diseases include Equine encephalomyelitis, Strangles tetanus equine, Influenza equine, Rhinopneumonitis. Aquaculture diseases include Vibriosis, Pasteurellosis, Furunculosis. Major animal vaccine production technologies are live attenuated vaccines, inactivated vaccines, subunit vaccines, toxic vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Under livestock diseases category the bovine vaccine is applicable for Foot-and-mouth disease, Bovine viral diarrhea, Bovine clostridia disease, brucellosis, Infectious bovine rhinotracheitis etc. Under companion diseases category canine vaccines is applicable for Canine rabies, Canine distemper, Canine parvovirus, and Infectious canine hepatitis. Feline Vaccines is applicable for Feline rabies, Feline panleukopenia, Feline viral rhinotracheitis, and Feline leukemia. Small ruminant animal vaccine is applicable for small ruminant clostridia disease, Scabby mouth infection, Pneumonia & Septicemia, Pox and Ovine Johne’s disease. The DNA vaccines have the highest growth in veterinary vaccine technologies market in 2014.

The product segment animal vaccines market is further divided into livestock vaccine, porcine vaccines, poultry vaccines, equine vaccines, aquaculture vaccines, companion animal vaccines and other animal vaccines like vaccines for rabbits, deer, camels, elephants and bats. The companion animal vaccine in the product segment is the fastest-growing segment due to increase in growing pet population and increase of zoonotic diseases in humans. The growth of animal vaccines market is also fuelled by increasing investments by various government agencies, animal associations, and leading players; continuous innovations and introduction of new veterinary vaccines. The other key growth drivers are various technological innovations like DNA vaccines, animal health awareness in developing nations. On the parallel side increase in maintenance and storage costs of vaccines, increase in consumption of vegetarian food in major economies because of heightened risk in obesity and other chronic disorders, persistent economic downturn are the key factors restraining the growth of this market.

Breakthrough technology includes manufacturing and usage of DNA vaccines and other products ensuring increase in production and instant responses to immunity as compared to the conventional vaccines. Other driving factors like huge demand for various animal proteins which includes milk, meats, eggs and fishes and increase in the expenditure on healthcare sector which caters companion animals segment. To increase the awareness against heavy usage of antimicrobials the vaccine producers are significantly investing into NPD (New products development). Specific vaccines such as live bacterial vaccines and inactivated bacterial vaccines are being produced by local veterinary clinics or specialized vet meds manufacturing companies to meet product specific or on farm specific demands where there is none availability of commercial vaccines. Key leaders in the veterinary vaccines market are Bayer Healthcare from Germany, Bioniche Animal Health from Canada, Boehringer Ingelheim from Germany, Ceva from France, Elcano Animal Health from USA, Heska Co. from USA, Merck Animal Health from USA, Merial of Sanofi from USA, Virbac from France, and Zoetis of Pfizer from USA.   

Get a Sample Copy of This Report @  

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.


Contact Person:

Ryan Manuel

Research Support Specialist, USA



Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

Phone: 91-20-65300184


Visit Our Blog:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.